1. Introduction {#s1}
===============

Hypertension is a common chronic disease in the elderly and the prevalence of hypertension of this condition increases gradually with aging.[@b1] In elderly individuals with hypertension, high blood pressure is an important cause of cardiovascular diseases and mortality.[@b2] The initial stage in atherosclerotic formation and progression is vascular endothelial dysfunction, which plays a key role in systemic organ damage and subsequently leads to the deterioration of prognosis.[@b3] Endothelial dysfunction is induced by both traditional and non-traditional risk factors.[@b4] Among these factors, serum uric acid (SUA) is considered significant.[@b5] Notably, hypertension is frequently accompanied by elevated SUA level.[@b6] UA is the final product of purine metabolism in humans, and a high SUA level is considered an independent risk factor of cardiovascular disease and metabolic syndrome, particularly in individuals with hypertension and diabetes.[@b7],[@b8]

Previous studies have revealed that elevated of SUA levels are associated with endothelial dysfunction.[@b9],[@b10] However, no study has evaluated the relationship between SUA and endothelial dysfunction assessed using reactive hyperemia index (RHI) among elderly patients with untreated mild hypertension. The current study aimed to investigate the cross-sectional relationship between SUA level and endothelial dysfunction using RHI in individuals aged ≥ 60 years with untreated mild hypertension. Moreover, a gender specific analysis was performed due to the remarkable differences in UA levels between men and women.

2. Methods {#s2}
==========

2.1. Subjects {#s2a}
-------------

We performed a retrospective analysis of 123 elderly patients from Cardiology Department of Xuanwu Hospital (China), who underwent EndoPAT testing. All patients were diagnosed with hypertension for the first time, or they stopped taking antihypertensive drugs for at least three months and were classified based on blood pressure (mild hypertension). To diminish some confounders that may affect endothelial function, we excluded patients receiving lipid-lowering drugs, those with poor glycemic control (fasting blood glucose ≥ 11.1 mmol/L); those with comorbidities (such as nephropathy and peripheral neuropathy), those with unstable angina, myocardial infarction within 6 months, heart failure, severe arrhythmia, stroke within 3 months, impaired liver function (alanine aminotransferase and/or aspartate aminotransferase exceeding the upper limit of normal value by one time or above) or impaired renal function (creatinine level exceeding the upper limit of normal value).

2.2. Blood pressure measurements {#s2b}
--------------------------------

Clinic blood pressure was assessed three times using a mercury sphygmomanometer in while the patient was sitting after resting for at least 5 min. The mean of the three measured values was considered for analysis. Mild hypertension, the same as hypertension class I, was defined as systolic blood pressure (SBP) of 140--159 mmHg and/or diastolic blood pressure (DBP) of 90--99 mmHg.[@b11]

2.3. Clinical and biochemical data {#s2c}
----------------------------------

Physical examination and laboratory tests were obtained from the medical records of all participants during their first visit at the outpatient cardiology department. During the physical examination, data about age, complications, use of medications, highest blood pressure, waist circumference, hip circumference, height and weight. Moreover, the following equations were used: body mass index (BMI) = weight (kg)/height (m)^2^; and waist-to-hip ratio (WHR) = waist circumference (cm)/hip circumference (cm). The levels of allanine aminotransferase, aspartate transaminase, fasting blood glucose, triglyceride, cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein and uric acid were measured at the clinic.

2.4. Endothelial dysfunction measurements {#s2d}
-----------------------------------------

Endothelial function was assessed via peripheral arterial tonometry, which is a non-invasive method, using the EndoPAT 2000 device (Itamar Medical Ltd., Caesarea, Israel). Two flexible probes were placed on the index fingers of both hands along with inflatable cuffs and plethysmographic biosensors. The baseline data of the two sides were collected after resting for 30 min.[@b12] Then, cuff occlusion in the left forearm lasted for 5 min, which resulted in transitory ischemia. All data of both fingers were recorded in the process of occlusion and post-occlusion. In the course, the parameter of RHI was calculated via an automated analysis. Thus, an RHI ≥ 1.67 indicated a normal vascular endothelial function, whereas an RHI \< 1.67 represented an abnormal vascular endothelial function.[@b13]

2.5. Statistical analysis {#s2e}
-------------------------

Data analysis was performed using the Statistical Package for the Social Sciences software version 23. Continuous variables are expressed as mean ± SD and were compared using student\'s *t*-tests. Categorical variables are expressed as percentages and compared using *χ*^2^ test. SUA level and traditional risk factors were selected for univariate correlation analysis and entered into the multiple regression model. Finally, the ability of SUA level in predicting dysfunction among elderly patients was assessed the area under the receiving operative characteristic (ROC) curve. A *P*-value \< 0.05 was considered statistically significant and all confidence intervals were within the 95% range.

3. Results {#s3}
==========

3.1. Clinical, and biochemical characteristics of the study population {#s3a}
----------------------------------------------------------------------

[Table 1](#jgc-17-05-264-t01){ref-type="table"} presents the clinical and biochemical characteristics of the study population. A total of 123 participants (62 men and 61 women) were included and the mean age was 69.27 ± 5.76 years (range 60--78 years). Among them, 54 (43.90%) had endothelial dysfunction, which was defined as RHI \< 1.67. The SUA level for the RHI ≥ 1.67 group was significantly higher than that of the RHI \< 1.67 group (298.04 ± 82.39 *vs*. 332.22 ± 79.60 µmol/L, respectively, *P* \< 0.01). This difference was still observed in the subgroup of men, but not in women. Moreover, patients with an RHI ≥ 1.67 had a higher WHR (*P* \< 0.01), and this result was also observed among women (*P* \< 0.05). No significant differences were observed in terms of other clinical and biochemical data (*P* \> 0.05).

###### The clinical, and biochemical characteristics of the study population.

  Valuables               RHI ≥ 1.67      RHI \< 1.67         *P*^a^           *P*^b^           *P*^c^                                            
  -------------------- ---------------- ---------------- ---------------- ---------------- ----------------- ---------------- --------- --------- ---------
  *N*                         69               36               33               54               26                28          0.72       \-        \-
  Age, yrs               69.32 ± 5.82     69.08 ± 5.84     69.58 ± 5.87     69.22 ± 5.76     69.15 ± 5.45      69.29 ± 6.13     0.93      0.96      0.85
  Smoker                 19 (23.19%)      16 (44.44%)       3 (9.09%)       14 (25.93%)       11 (42.31%)       3 (10.71%)      1.00      1.00      1.00
  BMI, kg/m^2^           25.17 ± 3.84     25.10 ± 4.37     25.27 ± 3.23     25.27 ± 3.23     25.69 ± 3.76      24.90 ± 2.65     0.88      0.58      0.63
  WHR                    0.89 ± 0.07      0.92 ± 0.06      0.87 ± 0.06      0.86 ± 0.06       0.89 ± 0.05      0.84 ± 0.06     \< 0.01    0.11     \< 0.05
  ALT, U/L              23.24 ± 12.66    24.99 ± 14.69     21.33 ± 9.88    23.61 ± 12.31     27.15 ± 15.06    20.32 ± 13.96     0.87      0.57      0.67
  AST, U/L              23..82 ± 5.30     24.27 ± 5.50     23.33 ± 5.10     24.70 ± 7.36     26.04 ± 9.19      23.46 ± 4.97     0.44      0.35      0.92
  Creatinine, mmol/L    61.86 ± 14.45    68.78 ± 15.13     54.30 ± 8.97    63.85 ± 13.90     72.62 ± 11.48    55.71 ± 10.72     0.44      0.28      0.58
  FBP, mmol/L            5.40 ± 0.73      5.38 ± 0.83      5.41 ± 0.75      5.53 ± 0.79       5.43 ± 0.83      5.62 ± 0.75      0.32      0.78      0.28
  TG, mmol/L             2.06 ± 1.44      2.47 ± 1.78      1.61 ± 0.72      2.07 ± 1.43       2.44 ± 1.75      1.72 ± 0.96      0.97     \< 0.01    0.95
  TCH, mmol/L            5.20 ± 0.77      5.13 ± 0.77      5.27 ± 0.78      5.24 ± 1.13       4.96 ± 1.17      5.50 ± 1.04      0.83      0.96      0.63
  LDL-C, mmol/L          3.26 ± 0.72      3.14 ± 0.76      3.39 ± 0.66      3.27 ± 0.89       3.16 ± 0.83      3.36 ± 0.96      0.96      0.47      0.33
  HDL-C, mmol/L          1.35 ± 0.32      1.30 ± 0.28      1.41 ± 0.35      1.44 ± 0.63       1.22 ± 0.29      1.66 ± 0.78      0.29      0.30      0.11
  UA, µmol/L            298.04 ± 82.39   302.38 ± 94.30   293.30 ± 68.21   332.22 ± 79.60   375.31 ± 743.17   292.21 ± 63.52   \< 0.05   \< 0.01    0.95
  SBP, mmHg             137.75 ± 11.99   136.00 ± 9.80    139.67 ± 13.91   138.74 ± 11.92   138.07 ± 10.46    139.36 ± 13.29    0.65      0.43      0.93
  DBP, mmHg              85.93 ± 8.56     85.44 ± 7.17     86.45 ± 9.98    87.91 ± 13.11     90.65 ± 12.17    85.36 ± 13.29     0.32     \< 0.05    0.71
  MAP, mmHg             103.20 ± 7.99    102.30 ± 6.50    104.19 ± 9.26    104.85 ± 11.07    106.46 ± 9.79    103.36 ± 12.13    0.34     \< 0.05    0.76
  PP, mmHg              51.83 ± 12.21     50.44 ± 7.17    53.21 ± 13.96    50.83 ± 13.30     47.42 ± 15.92     54.00 ± 9.53     0.67      0.35      0.80

Data are presented as mean ± SD or *n* (%). ^a^*P*-values derived from compare between the RHI ≥ 1.67 group and RHI \< 1.67 group; ^b^*P*-values derived from compare between the RHI ≥ 1.67 group and RHI \< 1.67 group among the men; ^c^*P*-values derived from compare between the RHI ≥ 1.67 group and RHI \< 1.67 group among the women. ALT: alanine aminotransferase; AST: aspartate transaminase; BMI: body mass index; DBP: diastolic blood pressure; FBP: fasting blood glucose; HDL-C: high-density lipoprotein; HT: hypertension; LDL-C: low density lipoprotein cholesterol; MAP: mean arterial pressure; PP: pulse pressure; RHI: reactive hyperemia index; SBP: systolic blood pressure; TCH: cholesterol; TG: triglyceride; UA: uric acid; WHR: waist-to-hip ratio.

3.2. Univariate analysis and multiple regression analysis of RHI {#s3b}
----------------------------------------------------------------

[Table 2](#jgc-17-05-264-t02){ref-type="table"} depicts that SUA level was an independent determinant of RHI. In the univariate analysis, RHI was negatively associated with SUA level. Furthermore, the multiple regression analysis revealed that SUA level (*β* = −0.288, *P* = 0.014) and WHR (*β* = 0.246, *P* = 0.024) were still considered the independent predictors of RHI after adjusting for other traditional cardiovascular risk factors. This model explained 13.5% of the variance of RHI.

###### Univariate analysis and multiple regression analysis of RHI in patients with untreated mild hypertension in the elderly.

  Variable      Univariate analysis   Multiple regression analysis (*R*^2^ = 0.135)            
  ------------ --------------------- ----------------------------------------------- --------- -------
  Gender               0.050                              0.586                        0.051    0.653
  Age                  0.099                              0.275                        0.077    0.443
  WHR                  0.079                              0.383                        0.246    0.024
  Smoke                0.015                              0.870                        0.090    0.392
  Creatinine          --0.121                             0.183                       --0.138   0.262
  FBP                 --0.148                             0.102                       --0.123   0.194
  TG                  --0.093                             0.305                        0.058    0.591
  HDL-C                0.057                              0.531                       --0.001   0.991
  UA                  --0.246                             0.006                       --0.288   0.014
  SBP                 --0.015                             0.869                       --0.009   0.926
  DBP                 --0.105                             0.248                       --0.044   0.670

DBP: diastolic blood pressure; HDL-C: high-density lipoprotein; FBP: fasting blood glucose; WHR: waist-to-hip ratio; RHI: reactive hyperemia index; SBP: systolic blood pressure; TG: triglyceride; UA: uric acid.

In the subgroup analysis, RHI was still negatively associated with SUA level in men ([Table 3](#jgc-17-05-264-t03){ref-type="table"}), but not in woman ([Table 4](#jgc-17-05-264-t04){ref-type="table"}). The multiple regression analysis revealed that SUA level (*β* = −0.430, *P* = 0.008) remained an independent predictor of RHI in men.

###### Univariate analysis and multiple regression analysis of RHI in men.

  Variable      Univariate analysis   Multiple regression analysis (*R*^2^ = 0.307)            
  ------------ --------------------- ----------------------------------------------- --------- -------
  Age                  0.113                              0.383                       --0.013   0.924
  WHR                  0.063                              0.625                        0.149    0.315
  Smoke                0.096                              0.460                        0.166    0.210
  Creatinine          --0.081                             0.532                       --0.014   0.930
  FBP                 --0.154                             0.232                       --0.149   0.266
  TG                  --0.065                             0.616                        0.266    0.108
  HDL-C                0.274                              0.031                        0.257    0.097
  UA                  --0.386                             0.002                       --0.430   0.008
  SBP                 --0.184                             0.153                       --0.175   0.167
  DBP                 --0.190                             0.140                       --0.044   0.739

DBP: diastolic blood pressure; FBP: fasting blood glucose; HDL-C: high-density lipoprotein; RHI: reactive hyperemia index; SBP: systolic blood pressure; TG: triglyceride; UA: uric acid; WHR: waist-to-hip ratio.

###### Univariate analysis and multiple regression analysis of RHI in women.

  Variable      Univariate analysis   Multiple regression analysis (*R*^2^ = 0.148)            
  ------------ --------------------- ----------------------------------------------- --------- -------
  Age                  0.090                              0.491                        0.119    0.441
  WHR                  0.141                              0.278                        0.225    0.185
  Smoke               --0.026                             0.844                       --0.024   0.866
  Creatinine          --0.157                             0.226                       --0.116   0.441
  FBP                 --0.155                             0.232                       --0.215   0.145
  TG                  --0.141                             0.279                       --0.151   0.307
  HDL-C               --0.032                             0.809                       --0.064   0.686
  UA                  --0.126                             0.334                       --0.073   0.683
  SBP                  0.065                              0.616                        0.233    0.192
  DBP                 --0.046                             0.727                       --0.108   0.523

DBP: diastolic blood pressure; FBP: fasting blood glucose; HDL-C: high-density lipoprotein; RHI: reactive hyperemia index; SBP: systolic blood pressure; TG: triglyceride; UA: uric acid; WHR: waist-to-hip Ratio.

3.3. ROC curves of the serum uric acid for predicting endothelial dysfunction {#s3c}
-----------------------------------------------------------------------------

The ROC curve is depicted in [Figure 1](#jgc-17-05-264-g001){ref-type="fig"}. The ROC curve analysis revealed that the optimal cutoff value for SUA in predicting endothelial dysfunction among elderly individuals with mild hypertension was 293.5 µmol/L, with a sensitivity of 70.4% and a specificity of 58.0%, and the area under the curve was 0.624 (95% CI: 0.525--0.723, *P* = 0.018). In the subgroup analysis, the cutoff value was 287.0 µmol/L in men, with a sensitivity of 92.3% and a specificity of 58.8%, and the area under the curve was 0.763 (95% CI: 0.613--0.858, *P* = 0.002). However, the ROC curve analysis in women did not provide valuable information.

![The receiver operating characteristic curves of the serum uric acid in the elderly (A), men (B) and women (C) for predicting endothelial dysfunction.\
AUC: area under curve.](jgc-17-05-264-g001){#jgc-17-05-264-g001}

4. Discussion {#s4}
=============

Endothelial dysfunction is defined as an imbalance between vasodilation and vasoconstriction. This condition is mainly characterized by a decrease in the bioavailability of nitric oxide (NO), which plays a crucial role in maintaining vascular health by regulating vasomotor function.[@b14] Endothelial dysfunction is associated with traditional cardiovascular risk factors (e.g., diabetes and dyslipidemia)[@b15] and the use of statins, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and other drugs can affect endothelial function.[@b16] Based on the above mentioned factors, we eliminated the influence of other confounding factors based on the exclusion criteria.

This study used RHI assessed using EndoPAT 2000 to evaluate endothelial function. In previous clinical studies, the most commonly used technique is flow-mediated vasodilatation of the brachial artery.[@b17] However, its application depends on the experienced of operator.[@b18] The EndoPAT 2000 device using peripheral arterial tonometry (PAT) is easy-to-use and considered an operator-independent alternative for a noninvasive measurement of the endothelial function in the peripheral microcirculation.[@b19] Prior studied have shown that RHI is an independent predictor of cardiovascular event.[@b20]

This retrospective study first explored whether lower SUA levels were associated with better endothelial function among elderly patients with untreated mild hypertension. Result showed a negative and independent association between SUA level and endothelial dysfunction among elderly patients with untreated mild hypertension after adjusting for cardiovascular factors (*P* = 0.014). Furthermore, in subsequent subgroup analyses, a similar result was observed in men, but not in women. The multiple regression analysis reveals that SUA level was an independent predictor of RHI. However, the *R*^2^ of the model were only 0.135 and 0.307 in all participants and men, respectively. This result indicates that the index was significantly based on other unknown non-traditional clinical variables. In other populations with different clinical complications, the results about the association between SUA level and endothelial dysfunction were similar. Tanaka, *et al*.[@b3] have assessed both the cross-sectional and longitudinal association between SUA level and flow-mediated vasodilatation in participants with treated hypertension, and a linear negative association was observed at baseline and follow-up period. Several studies have shown a high SUA level is an independent predictor of endothelial dysfunction in participants with kidney disease.[@b21],[@b22] Moreover, Gaubert, *et al*.[@b10] demonstrated SUA level remained inversely associated with RHI, even after adjusting for traditional cardiovascular risk factors during the first episode of acute coronary syndrome. Meanwhile, we noted a difference in the relationship between SUA level and RHI in terms of sex, as observed in other studies in which positive results for the analysis of SUA were found only in men or women. The most likely explanation for this phenomenon is that SUA level is regulated by sex hormones and gene expression.[@b23],[@b24]

Prior studies have indicated that UA is involved in vascular tone and endothelium function via different mechanisms.[@b25] First, uric acid can reduce the level of L-arginine required for NO generation by enhancing the activity of arginase, and consequently reducing NO production and bioavailability.[@b26] Furthermore, uric acid also participates in C-reactive protein or calcium ion-induced instability of endothelial nitric oxide synthase (eNOS) mRNA in endothelial cells, which decreases eNOS expression and NO production.[@b26] Third, an increase of uric acid promotes oxidative stress and inflammation, which then enhances damage and even apoptosis of vascular endothelial cell.[@b27]--[@b29] In addition, several trials have reported that a lower uric acid level can improve endothelial function.[@b5] For example, allopurinol, a type of xanthine oxidase inhibitors, can improve endothelial dysfunction[@b30], as a direct consequence of the reduced UA levels, and superoxide anions mediated by xanthine oxidase.[@b31]

Finally, based on the ROC curve analysis, a SUA level ≥ 293.5 µmol/L and ≥ 287.0 µmol/L had a predictive value for endothelial dysfunction in all participants and in men, respectively. Such result indicates that the SUA level should be controlled more strictly to prevent the worsening of endothelial dysfunction among elderly patients with hypertension, particularly men. Some researchers proposed that the poor outcome associated with UA, which is free of crystal formation, can be observed even in the normal range.[@b32]

However, a paradoxically positive association was observed between RHI and WHR. Elevated WHR indicated central adiposity, one of important risk factor of cardiovascular diseases. To the best of our knowledge, the perplexing relationships between RHI and other cardiovascular risk factors, such as troponins level and carotid artery intima-media thickness, has been observed in previous trials.[@b17] Whether this result can be explained by the reverse epidemiology phenomenon or there is another mechanism underlying the relationship between RHI and WHR remains unknown. To obtain a more precise answer, this question must be subsequently assessed.

The current study had some limitations. First, this study had a cross-sectional design, and the causal relationship between SUA level and endothelial dysfunction could not be determined. Second, we only recruited elderly patients with hypertension who did not receive treatment, and several exclusion criteria were set to reduce the effect of other factors. Thus, only a small sample size was included, which might affected the statistical significance of the results. Third, the value of RHI was not measured repeatedly to reduce the random error, even though the RH-PAT method had been proven to have an excellent reproducibility.

In conclusion, a high SUA level can predict a lower RHI value, which is indicative of endothelial dysfunction. This condition is a known risk factor of adverse cardiovascular events in the elderly population with untreated mild hypertension, particularly men. For the abovementioned population, strict control of SUA level is likely to be beneficial for endothelial function. Therefore, when screening elderly patients with hypertension, particularly men, monitoring of the level of SUA, which is an inexpensive and easily obtainable biomarker, may provide information about endothelial dysfunction.
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